Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 24, 1994 - Issue 7
15
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Dose-ranging study of NG-nitro-L-arginine pharmacokinetics in rats after bolus intravenous administration

, , , , &
Pages 663-669 | Received 08 Nov 1993, Published online: 27 Aug 2009

References

  • Bivin W. S., Crawford M. P., Brewer N. R. Morphophysiology. The Laboratory Rat. Biology and Diseases, H. J. Baker, J. R. Lindsey, S. H. Weisbroth. Academic. 1979; Vol. 1: 74–103
  • Gibaldi M., Perrier D. Pharmacokinetics2nd Edn. Marcel Dekker, New York 1982
  • Huber S., Grohs J. G., Schwarzacher S., Raberger G. Oral NG-nitro-L-arginine in conscious dogs: 24 hour hypertensive response in relation to plasma levels. Aminoacids 1992; 2: 225–232
  • Igari Y., Sugiyama Y., Awazu S., Hanano M. Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat. Journal of Pharmacokinetics and Biopharmaceutics 1982; 10: 53–75
  • Komura H., Fukui H., Sasaki H., Morino A. Pharmacokinetic analysis of enterohepatic circulation of 4-[2-(4-isopropylbenzamido)ethoxy]benzoic acid—effect of intramolecular rearrangement of its acyl glucuronide. Drug Metabolism and Disposition 1992; 20: 585–591
  • Kovach A. G. B., Szabo C., Benyo Z., Csaki C., Greenberg J. H., Reivich M. Effects of NG-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat. Journal of Physiology 1992; 449: 183–196
  • Krejcy K., Schwarzacher S., Raberger G. Distribution and metabolism of NG-nitro-L-arginine and NG-nitro-L-arginine methyl ester in canine blood in vitro. Naunyn-Schmiedeberg's Archive of Pharmacology 1993; 347: 342–345
  • Liu M. J., Brouwer K. L. R., Pollack G. M. Pharmacokinetics and pharmacodynamics of valproate analogs in rats. 3. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat. Drug Metabolism and Disposition 1992; 20: 810–815
  • Liu M. J., Pollack G. M. Pharmacokinetics and pharmacodynamics of valproate analogs in rats. 2. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid. Biopharmaceutics and Drug Disposition 1993; 14: 325–339
  • Molnár M., Hertelendy F. N-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. American Journal of Obstetrics and Gynecology 1992; 166: 1560–1567
  • Moore P. K., Al-Swayeh O. A., Chong N. W. S., Evans R. A., Gibson A. L-NG-nitroarginine (L-NOARG), a novel, L-arginine reversible inhibitor of endothelium-dependent vasodilation in vitro. British Journal of Pharmacology 1990; 99: 408–412
  • Narkowicz C. K., Vial J. H., Xu X. F. Delayed recovery from NG-nitro-L-arginine in the conscious sheep. Clinical and Experimental Pharmacology and Physiology 1991; 18: 843–846
  • Peris-Ribera J. E., Torres-Molina F., Garcia-Carbonell M. C., Aristorena J. C., Pla-Delfina J. M. Pharmacokinetics and bioavailability of diclofenac in the rat. Journal of Pharmacokinetics and Biopharmaceutics 1991; 19: 647–665
  • Piotrovskij V. K. Statistical moments method and model-independent characteristics of drug distribution and elimination. Khimiko-Farmatsevtitcheskij Zhurnal 1984; 18: 845–849
  • Piotrovskij V. K., Kállay Z., Horecky J., Trnovec T., Raberger G., Krejcy K. NG-nitro-L-arginine is not involved in enterohepatic cycling in rats. Drug Metabolism and Disposition 1994; 22: 338–339
  • Piotrovskij V. K., Kállay Z., Krejcy K., Horecky J., Trnovec T., Raberger G. NG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks. Drug Metabolism and Disposition 1993; 21: 962–964
  • Pucci M. L., Lin L., Nasjletti A. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin. Journal of Pharmacology and Experimental Therapeutics 1992; 261: 240–245
  • Rees D. D., Palmer R. M. J., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology 1990; 101: 746–752
  • Wang Y. X., Zhou T., Pang C. C. Y. A comparison of the inhibitory effects of sodium nitroprusside, pinacidil and nifedipine on pressor response to NG-nitro-L-arginine. British Journal of Pharmacology 1993; 108: 398–404
  • Zhou H. W., Shen J. Q., Lu M., Liang W. Q., Lin W., Zhao W. H. Pharmacokinetic analysis of enterohepatic circulation of piroxicam in rabbits. Acta Pharmacologica Sinica 1992; 13: 180–182

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.